← Browse by Condition
Medical Condition
parkinson 39 s disease pd
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for parkinson 39 s disease pd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT07142044 Phase 1, Phase 2
Recruiting
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Enrollment
18 pts
Location
United States
Sponsor
EicOsis Human Health Inc.
NCT06742450
Recruiting
Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease
Enrollment
180 pts
Location
China
Sponsor
Xuanwu Hospital, Beijing
NCT06634641 Phase 4
Recruiting
Clozapine-related Immunodeficiency in Parkinsons Disease
Enrollment
24 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology